What is Meg Bradbury email address?

Meg Bradbury's primary email address is **********@uniqure.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Meg Bradbury work for?

Meg Bradbury is a Senior Genetic Counselor at Sarepta Therapeutics.

Where Meg Bradbury graduated from?

Meg Bradbury holds a degree in The objective of the Clinical and Translational Research program is to develop the clinical and translational research capabilities of research professionals, junior faculty, and scientists. This program responds to the National Institutes of Health (NIH) vision for new approaches to developing and preparing researchers who can meet the needs of a more “translational” approach to research. Graduates of the program will have the skills, knowledge, and experience needed to fill any number of clinical and translational research professions from funded scientists, clinical personnel, and those who mediate for better policy about health. Show less from The George Washington University School of Medicine and Health Sciences.

How can I directly contact Meg Bradbury?

To contact Meg Bradbury directly, you can use the email address **********@uniqure.com. Complete contact information is available upon registration with Muraena.

Who is Meg Bradbury?

Meg Bradbury is a seasoned executive with a strong background in translational medicine and clinical development. Currently serving as the Executive Director and Global Program Team Leader at Sarepta Therapeutics, she leads innovative gene therapy programs targeting neurological disorders. With a Master's degree in Medical Genetics and additional training in Clinical and Translational Research, Meg blends scientific expertise with strategic leadership. Throughout her career, she has held key roles at organizations like uniQure and AveXis, where she has significantly contributed to the advancement of gene therapies. Meg is known for her patient-centric approach in clinical trial design and her ability to foster collaboration across multidisciplinary teams. An invited speaker at various conferences, she shares her insights on gene therapy and clinical development. Her passion for improving patient outcomes drives her commitment to excellence in clinical research and development.